Galapagos NV - Product Pipeline Review - 2016 - Global Markets Direct - Market Research

Galapagos NV - Product Pipeline Review - 2016

Galapagos NV - Product Pipeline Review - 2016 - Global Markets Direct - Market Research
Galapagos NV - Product Pipeline Review - 2016
Published Jul 13, 2016
64 pages — Published Jul 13, 2016
Price US$ 1,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Global Markets Directs, Galapagos NV - Product Pipeline Review - 2016, provides an overview of the Galapagos NVs pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Galapagos NV, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Galapagos NV
- The report provides overview of Galapagos NV including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Galapagos NVs pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Galapagos NVs out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Galapagos NVs strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Galapagos NV
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Galapagos NVs pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

  
Source:
Document ID
GMDHC08084CDB
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables51
  List of Figures51
Galapagos NV Snapshot61
  Galapagos NV Overview61
  Key Information61
  Key Facts61
Galapagos NV Research and Development Overview73
  Key Therapeutic Areas73
Galapagos NV Pipeline Review107
  Pipeline Products by Stage of Development101
  Pipeline Products Monotherapy111
  Pipeline Products Combination Treatment Modalities121
  Pipeline Products Partnered Products131
    Partnered Products/Combination Treatment Modalities141
  Pipeline Products Out-Licensed Products151
    Out-Licensed Products/Combination Treatment Modalities161
Galapagos NV Pipeline Products Glance174
  Galapagos NV Clinical Stage Pipeline Products171
    Phase II Products/Combination Treatment Modalities171
    Phase I Products/Combination Treatment Modalities181
  Galapagos NV Early Stage Pipeline Products191
    Preclinical Products/Combination Treatment Modalities191
    Discovery Products/Combination Treatment Modalities201
Galapagos NV Drug Profiles2123
  filgotinib211
    Product Description211
    Mechanism of Action211
    R&D Progress213
  GLPG-1205241
    Product Description241
    Mechanism of Action241
    R&D Progress242
  GLPG-1690261
    Product Description261
    Mechanism of Action261
    R&D Progress261
  GLPG-1837271
    Product Description271
    Mechanism of Action271
    R&D Progress272
  DT-200291
    Product Description291
    Mechanism of Action291
    R&D Progress292
  GLPG-1972311
    Product Description311
    Mechanism of Action311
    R&D Progress311
  GLPG-2222321
    Product Description321
    Mechanism of Action321
    R&D Progress321
  GLPG-2451331
    Product Description331
    Mechanism of Action331
    R&D Progress331
  MOR-106341
    Product Description341
    Mechanism of Action341
    R&D Progress342
  GLPG-1492361
    Product Description361
    Mechanism of Action361
    R&D Progress361
  GLPG-1790371
    Product Description371
    Mechanism of Action371
    R&D Progress371
  GLPG-1837 + GLPG-2222 + GLPG-2665381
    Product Description381
    Mechanism of Action381
    R&D Progress381
  GLPG-2534391
    Product Description391
    Mechanism of Action391
    R&D Progress391
  GLPG-2665401
    Product Description401
    Mechanism of Action401
    R&D Progress401
  GLPG-2737411
    Product Description411
    Mechanism of Action411
    R&D Progress411
  GLPG-2851421
    Product Description421
    Mechanism of Action421
    R&D Progress421
  GLPG-2938431
    Product Description431
    Mechanism of Action431
    R&D Progress431
Galapagos NV Pipeline Analysis444
  Galapagos NV Pipeline Products by Target441
  Galapagos NV Pipeline Products by Route of Administration451
  Galapagos NV Pipeline Products by Molecule Type461
  Galapagos NV Pipeline Products by Mechanism of Action471
Galapagos NV Recent Pipeline Updates4812
Galapagos NV Dormant Projects601
Galapagos NV Discontinued Pipeline Products611
  Discontinued Pipeline Product Profiles611
    GLPG-0187611
    GLPG-0259611
    GLPG-1179611
    GLPG-1205611
    GLPG-1332611
    GLPG-1577611
Galapagos NV Locations And Subsidiaries621
  Head Office621
  Other Locations &Subsidiaries621
Appendix632
  Methodology631
  Coverage631
  Secondary Research631
  Primary Research631
  Expert Panel Validation631
  Contact Us631
  Disclaimer641

Table Of Contents

Global Markets Direct - Market Research—Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

About the Author


Cite this Report

  
MLA:
Global Markets Direct - Market Research. "Galapagos NV - Product Pipeline Review - 2016" Jul 13, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Galapagos-NV-Product-Pipeline-Review-2016-2088-16182>
  
APA:
Global Markets Direct - Market Research. (2016). Galapagos NV - Product Pipeline Review - 2016 Jul 13, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Galapagos-NV-Product-Pipeline-Review-2016-2088-16182>
  
US$ 1,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.